Cargando…
A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
Chemotherapy is the most common and powerful cancer treatment. Although the nasty side effects seriously influence the clinical practice, no better ways can displace it. Therefore, searching for safe and effective strategies designed to ameliorate chemotherapy-induced toxicity has become an urgent i...
Autores principales: | You, Jieshu, Gao, Fei, Tang, Hailin, Peng, Fu, Jia, Lei, Huang, Kun, Chow, Kinlong, Zhao, Jiaqi, Liu, Huanlan, Lin, Yi, Chen, Jianping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636307/ https://www.ncbi.nlm.nih.gov/pubmed/31333784 http://dx.doi.org/10.7150/jca.32754 |
Ejemplares similares
-
Effect of a medicinal and edible decoction YH0618 on chemotherapy-induced dermatologic toxicity: a randomized controlled trial
por: You, Jieshu, et al.
Publicado: (2021) -
Effect of YH0618 soup on chemotherapy-induced toxicity in patients with cancer who have completed chemotherapy: study protocol for a randomized controlled trial
por: You, Jie-shu, et al.
Publicado: (2016) -
The effect and mechanism of YH0618 granule on chemotherapy- induced hair loss in patients with breast cancer: study protocol for a randomized, double-blind, multi-center clinical trial
por: You, Jie-shu, et al.
Publicado: (2019) -
Complete Genome Sequences of Multidrug-Resistant Campylobacter coli Strains YH501, YH503, and YH504, from Retail Chicken
por: He, Yiping, et al.
Publicado: (2022) -
Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy?
por: Kulsoom, Bibi, et al.
Publicado: (2018)